Fair Value Measurements - Additional Information (Detail) - shares	3 Months Ended	6 Months Ended
Jun. 30, 2025	Jun. 30, 2025
Public Warrant [Member]
Antidilutive securities excluded from the calculation of diluted loss per share	20,722,500	20,722,500
Private Placement Warrants
Antidilutive securities excluded from the calculation of diluted loss per share	12,757,500	12,757,500

Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482662/260-10-50-1

Name:	us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration